CLLS
Cellectis SA Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website cellectis.com
- Employees(FY) 231
- ISIN US15117K1034
Performance
+21.09%
1W
+15.67%
1M
+2.99%
3M
+29.71%
6M
+0.65%
YTD
+63.16%
1Y
Profile
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed or refractory for non-hodgkin lymphoma (NHL); and ALLO-715 for the treatment of multiple myeloma. It also develops UCART22 to treat B-cell acute lymphoblastic leukemia; UCARTCS1 and ALLO-605 for the treatment of multiple myeloma; ALLO-316 for renal cell carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART 20x22 for relapsed or refractory B-Cell NHL. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics; and collaboration and license agreement with Cytovia, as well as a collaboration agreement with AstraZeneca to develop novel cell and gene therapy candidate products. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.
Technical Analysis of CLLS 2024-05-03
Overview:
In analyzing the technical indicators for CLLS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-06 04:30
- 2024-05-05 16:22
- 2024-05-05 14:00
- 2024-05-02 18:10
Cellectis CFO Bing Wang Retires, Interim CFO Appointed(Yahoo Finance)
- 2024-05-02 04:30
- 2024-04-29 10:53
- 2024-04-29 04:46
- 2024-04-22 04:30
- 2024-04-10 04:30
- 2024-04-08 04:30
- 2024-04-04 04:30
- 2024-03-04 03:30
- 2024-02-02 03:30
- 2024-01-16 03:30
- 2024-01-08 03:30
- 2023-12-22 03:30
- 2023-12-01 03:30
- 2023-11-17 03:30
- 2023-11-14 13:30
- 2023-11-06 03:30
- 2023-11-03 04:30
- 2023-11-02 04:30
- 2023-11-01 04:30
- 2023-10-31 20:13
Why Is Cellectis (CLLS) Stock Up 175% Today?(Investorplace)
- 2023-10-31 20:02
- 2023-10-31 15:00
- 2023-10-31 04:30
- 2023-10-24 04:30
- 2023-10-12 04:30
- 2023-10-03 04:30
Page 1 of 4
previousnext